Cargando…

Mechanism of coordinated access to orphan drugs

Detalles Bibliográficos
Autores principales:	DeRidder, R, Adriaens, C, Kleinermans, D, Mortier, M, Quanten, A, Arickx, F
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3504549/ http://dx.doi.org/10.1186/1750-1172-7-S2-A24

Ejemplares similares

Market access of orphan drugs and the role of multi-criteria decision making
por: Simoens, Steven
Publicado: (2012)

Novel orphan medicines and abandoned pathways - the US Orphan Drug Act of 1983 and the impact on rare rheumatologic diseases and lysosomal storage disorders
por: Ries, Markus, et al.
Publicado: (2015)

Leveraging existing opportunities for improved Orphan Drug approval in the EU
por: Edfjäll, Catarina
Publicado: (2012)

EHMTI-0248. Evaluation of headache prevalence and characteristics in orphans aged 12-17
por: Senturk, A Ates, et al.
Publicado: (2014)

10th European Conference on Rare Diseases & Orphan Products (ECRD 2020)
Publicado: (2020)

What can we learn about joint degeneration from rare and orphan diseases?
por: Gallagher, JA
Publicado: (2015)

A coordinated EU approach to informed access decisions: CAVOD process proposals – the possibility to turn concept into reality?
por: Hughes-Wilson, Wills
Publicado: (2012)

Listening to children’s and parents’ voices: using patient reported outcomes to empower patients with orphan diseases and their parents
por: Abetz-Webb, Linda
Publicado: (2012)

Patient access to orphan drugs in France
por: Bourdoncle, Marion, et al.
Publicado: (2019)

Meeting abstracts from the 11th edition of the European conference on Rare Diseases & Orphan Products (ECRD) 2022
Publicado: (2023)

8th European Conference on Rare Diseases & Orphan Products (ECRD 2016): Edinburgh, UK. 26-28 May 2016
por: Schlander, Michael, et al.
Publicado: (2016)

The role of globalization in drug development and access to orphan drugs: orphan drug legislation in the US/EU and in Latin America
por: Arnold, Renée J.G., et al.
Publicado: (2015)

Reconciling uncertainty of costs and outcomes with the need for access to orphan medicinal products: a comparative study of managed entry agreements across seven European countries
por: Morel, Thomas, et al.
Publicado: (2013)

Analysis of patient access to orphan drugs in Turkey
por: Koçkaya, Güvenç, et al.
Publicado: (2021)

9th European Conference on Rare Diseases & Orphan Products (ECRD Vienna 2018): Vienna, Austria. 10-12 May 2018
Publicado: (2018)

National plans: case study Belgium
por: De Ridder, Ri
Publicado: (2012)

Rare Diseases and Orphan Drugs Accessibility in Bosnia and Herzegovina
por: Guzvic, Vladmiri, et al.
Publicado: (2018)

Supporting implementation through collaborative learning: facilitating access to clinical expertise
por: Bunger, Alicia C, et al.
Publicado: (2015)

A Retrospective Chart Review Evaluating the Relationship between Cancer Diagnosis and Residential Water Source on the Lower Eastern Shore of Maryland, USA
por: DeRidder, Angela, et al.
Publicado: (2020)

Obstacles in access to care for children
por: Simonnot, Nathalie, et al.
Publicado: (2015)

Molecular mechanisms of resistance to disease modifying antirheumatic drugs (DMARDs)
por: Jansen, G, et al.
Publicado: (2002)

Survival and recovery after pediatric hypothermic immersion injury achieved through coordinated multidisciplinary approach
por: Simon, B, et al.
Publicado: (2001)

A.V.A.: a novel approach to venous access
por: Lichtenthal, PR, et al.
Publicado: (1999)

The European challenges of funding orphan medicinal products
por: Szegedi, Márta, et al.
Publicado: (2018)

The Care Coordination Program: a virtually integrated care delivery model for complex, high-needs patients
por: Naidoo, R Moodley, et al.
Publicado: (2011)

Supporting access to alcohol and other drug treatment: the Los Angeles County screening, brief intervention, and referral to treatment project for short-term jail detainees
por: Lee, Anne, et al.
Publicado: (2012)

Orphans in the Market: The History of Orphan Drug Policy
por: Mikami, Koichi
Publicado: (2019)

Coordinated performance measurement and improvement efforts in California's safety net systems: early experience and lessons
por: Sarkar, Urmimala, et al.
Publicado: (2015)

Impact of aerosol particle size on drug deposition during mechanical ventilation: an in vitro evaluation
por: Fink, JB, et al.
Publicado: (2002)

Aortic valve replacement with 'stentless' versus mechanical prosthesis: what difference in postoperative ICU course?
por: Guarracino, F, et al.
Publicado: (1999)

Access to Orphan Drugs is a Challenge for Sustainable Management of Cystinosis in China
por: Li, Xiao-Qiao, et al.
Publicado: (2018)

Patient-centered care coordination: a qualitative study of the lived experience of residents in Philadelphia recovery homes
por: Miles, Jennifer, et al.
Publicado: (2015)

Podiatric intervention in managing the gait related symptoms of Developmental Coordination Disorder (Dyspraxia). A retrospective study
por: Hindmoor, Pamela
Publicado: (2014)

Unlicensed drug use on ICU
por: Goldsmith, C, et al.
Publicado: (2002)

Is it safe to allow general practitioners open access to breast imaging?
por: Clough, GR, et al.
Publicado: (2002)

Infrequent use of Public Access Defibrillation in spite of great benefit
por: Agerskov, Marianne, et al.
Publicado: (2015)

Infrequent use of Public Access Defibrillation in spite of great benefit
por: Agerskov, Marianne, et al.
Publicado: (2015)

Comparison of implementation success across three national initiatives to improve veterans' access to specialty care
por: Lowery, Julie C
Publicado: (2015)

Coordination of the canonical and noncanonical IKK/NF-κB signaling pathways in HTLV-I Tax-mediated tumorigenesis
por: Fu, Jing, et al.
Publicado: (2011)

Negotiating prices of drugs for rare diseases
por: Henrard, Séverine, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_nlnj8ma4b3bct6nhdqfu0rlib6